The Senate panel responsible for federal appropriations legislation overwhelmingly passed a bill last week that would increase funding for the [...] …
Month: August 2024
Pharmaceutical manufacturers Sanofi, GlaxoSmithKline (GSK) and Viatris are fully or partially exempting additional states from their 340B contract pharmacy restrictions. [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Novartis is now the third drug manufacturer to challenge Kansas’ new law prohibiting drug manufacturers from restricting contract pharmacy access [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A long-awaited bipartisan senate bill to overhaul the 340B program will not be introduced prior to the August Congressional recess [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
The U.S. government is urging a federal appeals court to dismiss a lower court’s “erroneous” decision to dismiss a California [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Missouri’s new 340B contract pharmacy access law is getting increased attention in state primary races just days before voters head [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Editor’s Note: With 340B-related litigation heating up in several states following the enactment of new contract pharmacy access laws this [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
A powerful drug industry trade group has asked the U.S. Supreme Court to overturn a federal appeals court’s decision to [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
New legislation introduced in the U.S. House of Representatives would extend 340B program eligibility to qualifying hospitals in all five [...] …
Please Login or Become a Paid Subscriber to View this Content
If you are already a
Four more U.S. House Democrats recently signed on to co-sponsor a federal bill (H.R. 7635) that would bar drugmaker restrictions [...] …